Centrum Medyczne Pratia Poznan

Skórzewo 60-185

1 studies enrolling now · 5 studies all time

What they study most

CLL/SLL, Chemotherapeutic Toxicity, Colorectal Cancer Metastatic, DLBCL, Follicular Lymphoma, Heart Failure, Indolent Non-Hodgkin Lymphoma, Lymphoplasmacytic Lymphoma, MCL, MZL, Myelosuppression-Adult, NASH - Nonalcoholic Steatohepatitis

Studies at this site

• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart — Recruiting now
• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC): — Stopped early
• A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Participants With Indolent Non-Hodgkin Lymphoma — Completed
• HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL — Withdrawn before enrolling